Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
about
The GABAergic deficit hypothesis of major depressive disorder.Early-life serotonin dysregulation affects the migration and positioning of cortical interneuron subtypes.The effects of antidepressants appear to be rapid and at environmentally relevant concentrations.Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signallingAn investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics.Induction and potentiation of parturition in fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs).Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice.Nicotinic acetylcholine receptors as targets for antidepressants.Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivityInhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.Modulation of nicotinic acetylcholine receptors by strychnineNeuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.Physiological endpoints for potential SSRI interactions in fish.Cytisine-based nicotinic partial agonists as novel antidepressant compounds.Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.Biological basis for the co-morbidity between smoking and mood disorders.Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death.Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium.Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs.Riluzole blocks human muscle acetylcholine receptors.Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor.Inhibition of hippocampal excitability by citalopram.Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices.Gene expression in the brain from fluoxetine-injected mouse using DNA microarray.The antidepressant citalopram inhibits delayed rectifier outward K⁺ current in mouse cortical neurons.Fluoxetine effects on sheepshead minnow (Cyprinodon variegatus) locomotor activity.Makaluvamine G from the Marine Sponge Zyzzia fuliginosa Inhibits Muscle nAChR by Binding at the Orthosteric and Allosteric Sites.
P2860
Q30464954-B7EC3C3F-FC25-4FCE-BBD0-855F46AFC49BQ30823860-5A5FCBBA-76A8-4F22-B181-2FC253245A37Q30962448-1AF6FF1D-528C-4995-B0BD-651173A7EFA0Q33985983-9475D1D9-BC30-4D7A-8FCF-DC0879A269E5Q34414219-F5CBB5AE-D36D-46D9-80DE-EFF4E7A5E994Q34457113-A5563C75-125A-4B7A-9B71-35159099D3DCQ34692834-3C153E9C-FD6A-4AB5-8DD0-AEDEE1C8CE0FQ34761238-9F9B6DBE-5726-4687-B44C-9ED08CB2A4E0Q35028911-59E9A2C3-12AA-4CE0-A0A5-737E83AD6F15Q35045125-E2609D2C-F6B8-4473-8D3C-809C528D8482Q35045542-5EB399CF-C951-441D-B39A-D8240278EF22Q36459451-1ABFB522-89DA-42FA-AA05-521D28C2113FQ36578906-EEA66E7C-C6E5-4157-8933-FE6EDE612307Q36906632-A5F1D80E-FEC2-43C0-A151-B91E62D71550Q37103805-F60928C7-8ADE-49C0-ADD4-38EF21DC5EE1Q37162147-A4B1BA83-D5E2-4BD4-A0C5-F0504DAC21D8Q37238741-BE7C6323-21C4-409E-9A17-E538E3F7D789Q37253537-A840D3F3-AD04-4F53-8BA0-449833636CCDQ38620929-12101D61-D3B9-4834-BE86-DBD3C3EBD54AQ39218780-6FC6EF9E-C84B-4C73-93D1-99AF17DA7FE4Q40378569-A0DE4D0A-E18F-4486-9370-B0B4820C6BD0Q40971013-691A80D4-3C55-41D9-A2D7-705689A35E05Q42435124-B217DDD1-788A-4C9A-968E-F6D28F8C0BA7Q42461849-AEC9F59C-C573-42C5-B987-78C05315E953Q42640644-6A6D316A-E469-4C49-9CB2-5485E4373BDAQ43456577-42F29998-7EE1-4294-8A2C-573BB519672CQ43647176-778BC06A-CE65-490B-AD8E-8C08F6C56210Q43691281-7E174495-3DBF-4AE9-8C12-F35F003BBBDCQ43722405-F0D17CE6-55B4-4960-9456-7A71F8E0D0C0Q45049140-3DA4C5D0-DE44-4706-943C-CFE84356DE70Q48127922-423337C7-4F7F-466F-8F6D-A2E84553B7D0Q48370110-E2BC53E1-A64E-4775-BA6B-11F9DCC0DD69Q48875355-C90EB6F6-F89A-4A64-BBFC-DB74BA754FABQ51581755-F2EA76B8-CDFF-4D81-8B9E-D723503AF20AQ52621347-ED7A31D7-B674-4DBC-B839-10967914948B
P2860
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@ast
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@en
type
label
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@ast
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@en
prefLabel
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@ast
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@en
P2093
P2860
P356
P1476
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
@en
P2093
J García-Colunga
P2860
P304
P356
10.1073/PNAS.94.5.2041
P407
P577
1997-03-01T00:00:00Z